Following the Data to Thoughtful Choices - Risky Benefits S4, Ep. #16

In a politically-charged climate, it may be difficult to make clear decisions about your personal or your family’s health and wellness. A knee-jerk opinion may lead to a whole world of unintended consequences – as though you’re rolling the dice and you don’t fully know the rules of the game. High-stake circumstances can turn differences of opinion into great divides and the level of risk to your family may become a dangerous game. Listen as second-time Risky Benefits podcast guest, Dr. Jonathan Wiesen, CMO and MediOrbis founder, discusses how thinking through problems and following the data can lead to better health outcomes as you decide on levels of health or wellness risk. Dr. Wiesen covers topics surrounding the cost benefit of vaccination, medical weight loss drugs, Covid-19 impact, long-term health costs in employer-sponsored plans, and the network problem.MORE ABOUT OUR GUEST:Dr. Jonathon Wiesen, MDFounder, CMO MediOrbis; Medical Technology Advisor; Pulmonary and Critical Care MedicineMediOrbis.comDr. Jonathan Wiesen is a pulmonary and critical care physician, teacher, researcher and medical technology pioneer with a passion for clinical smedicine and telehealth innovation.Graduating from the Albert Einstein College of Medicine with distinction in research, he completed his training in internal medicine as well as pulmonary and critical care at the Cleveland Clinic - earning an advanced teaching degree and several teaching and research awards.As founder and chief medical officer of MediOrbis, he led the development of ground-breaking clinical programs for monitoring and managing chronic medical conditions and providing integrated medical specialty services. He also piloted the development of a global network of top physicians to deliver the company’s telemedicine services worldwide.Currently, Dr. Wiesen is a pulmonary specialist at Ben Gurion University’s Soroka Medical Center, where he directs the Cardio-Pulmonary Exercise Program. For many years, he has advised and assessed medical technology companies and served on the board of several companies, specializing in clinical assessment and due diligence.To listen in and subscribe to more episodes, visit our website: fbmc.com/podcast.